Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2024-08-01
|
| Series: | Journal of Clinical Interventional Radiology ISVIR |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786711 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850245384814723072 |
|---|---|
| author | Amelia Wong Shirley Cheng Anthony Herrera Linda Wong |
| author_facet | Amelia Wong Shirley Cheng Anthony Herrera Linda Wong |
| author_sort | Amelia Wong |
| collection | DOAJ |
| description |
Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver decompensation resulting in hospital admissions after TARE. |
| format | Article |
| id | doaj-art-05fc8f04068c4e48a3fec2f50305ceda |
| institution | OA Journals |
| issn | 2456-4869 |
| language | English |
| publishDate | 2024-08-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Journal of Clinical Interventional Radiology ISVIR |
| spelling | doaj-art-05fc8f04068c4e48a3fec2f50305ceda2025-08-20T01:59:29ZengThieme Medical and Scientific Publishers Pvt. Ltd.Journal of Clinical Interventional Radiology ISVIR2456-48692024-08-01080208308910.1055/s-0044-1786711Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient SelectionAmelia Wong0https://orcid.org/0009-0009-3350-6650Shirley Cheng1https://orcid.org/0000-0002-4717-4636Anthony Herrera2Linda Wong3https://orcid.org/0000-0003-3143-5384Department of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, United StatesJohn A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United StatesDepartment of Radiology, The Queen's Medical Center, Honolulu, Hawaii, United StatesDepartment of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, United States Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver decompensation resulting in hospital admissions after TARE.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786711hepatocellular carcinomayttrium 90transarterial radioembolization |
| spellingShingle | Amelia Wong Shirley Cheng Anthony Herrera Linda Wong Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection Journal of Clinical Interventional Radiology ISVIR hepatocellular carcinoma yttrium 90 transarterial radioembolization |
| title | Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection |
| title_full | Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection |
| title_fullStr | Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection |
| title_full_unstemmed | Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection |
| title_short | Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection |
| title_sort | predictors of hepatic decompensation after yttrium90 transarterial radioembolization optimizing patient selection |
| topic | hepatocellular carcinoma yttrium 90 transarterial radioembolization |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786711 |
| work_keys_str_mv | AT ameliawong predictorsofhepaticdecompensationafteryttrium90transarterialradioembolizationoptimizingpatientselection AT shirleycheng predictorsofhepaticdecompensationafteryttrium90transarterialradioembolizationoptimizingpatientselection AT anthonyherrera predictorsofhepaticdecompensationafteryttrium90transarterialradioembolizationoptimizingpatientselection AT lindawong predictorsofhepaticdecompensationafteryttrium90transarterialradioembolizationoptimizingpatientselection |